Long-term human B cell lines dependent on interleukin-4 and antibody to CD40 - PubMed (original) (raw)

Long-term human B cell lines dependent on interleukin-4 and antibody to CD40

J Banchereau et al. Science. 1991.

Abstract

CD40 is a 45- to 50-kilodalton transmembrane glycoprotein expressed on B lymphocytes, epithelial cells, and some carcinoma cell lines. Human resting B lymphocytes entered a state of sustained proliferation when incubated with both the mouse fibroblastic Ltk- cell line that had been transfected with the human Fc receptor (Fc gamma RII/CDw32) and monoclonal antibodies to CD40. In combination with interleukin-4, factor-dependent long-term normal human B cell lines were generated that were consistently negative for Epstein-Barr viral infection. Thus, cross-linking of CD40 is likely to represent an important phenomenon in the clonal expansion of B cells.

PubMed Disclaimer

Similar articles

• Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors.
  Fluckiger AC, Rossi JF, Bussel A, Bryon P, Banchereau J, Defrance T. Fluckiger AC, et al. Blood. 1992 Dec 15;80(12):3173-81. Blood. 1992. PMID: 1281692
• Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen.
  Rousset F, Garcia E, Banchereau J. Rousset F, et al. J Exp Med. 1991 Mar 1;173(3):705-10. doi: 10.1084/jem.173.3.705. J Exp Med. 1991. PMID: 1705282 Free PMC article.
• Engagement of CD40 lowers the threshold for activation of resting B cells via antigen receptor.
  Wheeler K, Pound JD, Gordon J, Jefferis R. Wheeler K, et al. Eur J Immunol. 1993 May;23(5):1165-8. doi: 10.1002/eji.1830230528. Eur J Immunol. 1993. PMID: 7682959
• Role of cytokines in human B lymphocyte growth and differentiation.
  Banchereau J, Blanchard D, Brière F, Galizzi JP, Garrone P, Hermann P, Lebecque S, Rousset F. Banchereau J, et al. Nouv Rev Fr Hematol (1978). 1993 Feb;35(1):61-6. Nouv Rev Fr Hematol (1978). 1993. PMID: 7685519 Review.
• CD23 and B cell activation.
  Gordon J. Gordon J. Clin Exp Allergy. 1992 Feb;22(2):199-204. doi: 10.1111/j.1365-2222.1992.tb03073.x. Clin Exp Allergy. 1992. PMID: 1533341 Review. No abstract available.

Cited by

• Defining bottlenecks and opportunities for Lassa virus neutralization by structural profiling of vaccine-induced polyclonal antibody responses.
  Brouwer PJM, Perrett HR, Beaumont T, Nijhuis H, Kruijer S, Burger JA, Bontjer I, Lee WH, Ferguson JA, Schauflinger M, Müller-Kräuter H, Sanders RW, Strecker T, van Gils MJ, Ward AB. Brouwer PJM, et al. Cell Rep. 2024 Sep 24;43(9):114708. doi: 10.1016/j.celrep.2024.114708. Epub 2024 Sep 6. Cell Rep. 2024. PMID: 39243373 Free PMC article.
• The Research Progress on Immortalization of Human B Cells.
  Xu H, Xiang X, Ding W, Dong W, Hu Y. Xu H, et al. Microorganisms. 2023 Dec 7;11(12):2936. doi: 10.3390/microorganisms11122936. Microorganisms. 2023. PMID: 38138080 Free PMC article. Review.
• Differentially activated B cells develop regulatory phenotype and show varying immunosuppressive features: a comparative study.
  Zheremyan EA, Ustiugova AS, Uvarova AN, Karamushka NM, Stasevich EM, Gogoleva VS, Bogolyubova AV, Mitkin NA, Kuprash DV, Korneev KV. Zheremyan EA, et al. Front Immunol. 2023 Sep 5;14:1178445. doi: 10.3389/fimmu.2023.1178445. eCollection 2023. Front Immunol. 2023. PMID: 37731503 Free PMC article.
• EBNA2-EBF1 complexes promote MYC expression and metabolic processes driving S-phase progression of Epstein-Barr virus-infected B cells.
  Beer S, Wange LE, Zhang X, Kuklik-Roos C, Enard W, Hammerschmidt W, Scialdone A, Kempkes B. Beer S, et al. Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2200512119. doi: 10.1073/pnas.2200512119. Epub 2022 Jul 20. Proc Natl Acad Sci U S A. 2022. PMID: 35857872 Free PMC article.
• The dark side of immunotherapy: pancreatic cancer.
  Mucciolo G, Roux C, Scagliotti A, Brugiapaglia S, Novelli F, Cappello P. Mucciolo G, et al. Cancer Drug Resist. 2020 May 11;3(3):491-520. doi: 10.20517/cdr.2020.13. eCollection 2020. Cancer Drug Resist. 2020. PMID: 35582441 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon

• Other Literature Sources

  • The Lens - Patent Citations

• Research Materials

  • NCI CPTC Antibody Characterization Program